{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T12:02:14Z","timestamp":1789128134606,"version":"build-2803163510"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,20]]},"DOI":"10.1097\/qad.0b013e32826fb6fc","type":"journal-article","created":{"date-parts":[[2007,8,9]],"date-time":"2007-08-09T03:05:33Z","timestamp":1186628733000},"page":"1711-1715","source":"Crossref","is-referenced-by-count":46,"title":["Pneumocystis jiroveci pneumonia prophylaxis is not required with a CD4+ T-cell count < 200 cells\/\u03bcl when viral replication is suppressed"],"prefix":"10.1097","volume":"21","author":[{"given":"Gianni E","family":"D'Egidio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kravcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis L","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D William","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A","family":"Fergusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B","family":"Angel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"R2-5-20210130","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.259.8.1185","article-title":"Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS","volume":"259","author":"Fischl","year":"1988","journal-title":"JAMA"},{"key":"R4-5-20210130","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/00002030-199909100-00007","article-title":"Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?","volume":"13","author":"Kirk","year":"1999","journal-title":"AIDS"},{"key":"R5-5-20210130","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1086\/315734","article-title":"Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4 T lymphocyte counts above prophylaxis thresholds","volume":"182","author":"Dworkin","year":"2000","journal-title":"J Infect Dis"},{"key":"R6-5-20210130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1086\/367659","article-title":"Discontinuation of secondary prophylaxis of Pneumocystis carinii pneumonia in Human Immunodeficiency Virus-infected patients: A randomized trial by the CIOP study group","volume":"36","author":"Mussini","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R7-5-20210130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00002030-200003100-00011","article-title":"Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy","volume":"14","author":"Soriano","year":"2000","journal-title":"AIDS"},{"key":"R8-5-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(98)07204-3","article-title":"Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy","volume":"353","author":"Schneider","year":"1999","journal-title":"Lancet"},{"key":"R9-5-20210130","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199904293401701","article-title":"Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1\u2013infected adults treated with combination antiretroviral therapy","volume":"340","author":"Furrer","year":"1999","journal-title":"N Engl J Med"},{"key":"R10-5-20210130","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1056\/NEJM200101183440301","article-title":"A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection","volume":"344","author":"Lopez Bernaldo de Quiros","year":"2001","journal-title":"N Engl J Med"},{"key":"R11-5-20210130","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(99)03287-0","article-title":"Discontinuation of Pneumocystis carinii pneumonia after start of highly active antiretroviral therapy in HIV-1 infection","volume":"353","author":"Weverling","year":"1999","journal-title":"Lancet"},{"key":"R12-5-20210130","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1086\/315471","article-title":"Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study","volume":"181","author":"Mussini","year":"2000","journal-title":"J Infect Dis"},{"key":"R13-5-20210130","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.qai.0000176591.06549.de","article-title":"Safe discontinuation of primary Pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy [Letter]","volume":"40","author":"Kumarasamy","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R14-5-20210130","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy","volume":"344","author":"Ledergerber","year":"2001","journal-title":"N Engl J Med"},{"key":"R15-5-20210130","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/00002030-200108170-00008","article-title":"A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to >200\u00d7106\/L","volume":"15","author":"Koletar","year":"2001","journal-title":"AIDS"},{"key":"R16-5-20210130","first-page":"1","article-title":"The design and analysis of cohort studies. In: Vol II \u2013The design and analysis of cohort studies","volume":"2","author":"Breslow","year":"1987","journal-title":"IARC SciPubl"},{"key":"R17-5-20210130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/clinids\/21.1.106","article-title":"Factors associated with the development of Pneumocystis carinii pneumonia in 5,025 European patients with AIDS","volume":"21","author":"Lundgren","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R18-5-20210130","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00002030-200207050-00021","article-title":"Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis","volume":"16","author":"Degen","year":"2002","journal-title":"AIDS"},{"key":"R19-5-20210130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002030-199902250-00006","article-title":"Prognostic value of plasma HIV RNA in the natural history of Pneumocystis carinii pneumonia, cytomegalovirus and Mycobacterium avium complex","volume":"13","author":"Lyles","year":"1999","journal-title":"AIDS"},{"key":"R20-5-20210130","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1097\/00002030-200109280-00012","article-title":"Viral load as an independent risk factor for opportunistic infections in HIV-infected adults and adolescents","volume":"15","author":"Kaplan","year":"2001","journal-title":"AIDS"},{"key":"R21-5-20210130","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00002030-199906180-00006","article-title":"Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections","volume":"13","author":"Williams","year":"1999","journal-title":"AIDS"},{"key":"R22-5-20210130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/498979","article-title":"Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy","volume":"193","author":"Weinberg","year":"1996","journal-title":"J Infect Dis"},{"key":"R23-5-20210130","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1016\/j.vaccine.2004.11.057","article-title":"Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose","volume":"23","author":"Fonseca","year":"2005","journal-title":"Vaccine"},{"key":"R24-5-20210130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1067\/mpd.2001.115972","article-title":"Immunization of HIV-infected children with varicella vaccine","volume":"139","author":"Levine","year":"2001","journal-title":"J Pediatr"},{"key":"R25-5-20210130","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/515658","article-title":"Risk factors for primary Pneumocystis carinii pneumonia in human immunodeficiency virus-infected adolescents and adults in the United States: reassessment of indications for chemoprophylaxis","volume":"178","author":"Kaplan","year":"1998","journal-title":"J Infect Dis"},{"key":"R26-5-20210130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0002-9343(99)80401-X","article-title":"The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease","volume":"98","author":"Bozzette","year":"1995","journal-title":"Am J Med"},{"key":"R27-5-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archinte.1992.00400150053009","article-title":"A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients","volume":"152","author":"Martin","year":"1992","journal-title":"Arch Intern Med"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002030-200708200-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:50:37Z","timestamp":1786035037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002030-200708200-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,20]]},"references-count":26,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e32826fb6fc","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8,20]]}}}